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Aim: Review the state of art on epicondylitis treatment and access the best management 
approach, focusing in the new promising treatments. 
Materials and methods: A research was performed on PubMed / MEDLINE Database 
including systematic reviews and clinical trials published between 2011 and 2016, using 
MeSH terms: "Tennis Elbow"," Tennis Elbow/ surgery "," Tennis Elbow/ therapy "," Tennis 
Elbow/ drug therapy "," Tennis Elbow/ rehabilitation ǲ. 
Results: The first approach on epicondylitis treatment is conservative with rest and activity 
modification, nonsteroidal anti-inflammatory drugs, bracing, physical therapy and kinesio 
taping therapy. In refractory cases, injection therapy and surgical intervention may be 
indicated. Despite its controversy, corticoidsteroid injection is still widely used when 
conservative treatment fails. Recent studies, are focusing on the potential use of growth 
factors as stimulant for tendon regeneration leading to the new promising injection 
therapies like autologous blood and platelet-rich plasma injections. Other promising 
therapies, namely, injection of botulinum toxin A, glycosaminoglycan and polidacanol are 
also being studied with still few long-term follow up studies proving their efficacy. Some 
pilot studies are also studying the possible use of stem cells on epicondylitis treatment.  
Conclusion: For the past 5 years, several studies have evaluated the effectiveness of 
different epicondylitis therapies and tried to describe a consensual treatment algorithm. 
Despite the abundance of studies, it still does not exist a globally accepted treatment 
algorithm. Whatsoever, a first approach consisting on a conservative treatment with rest 
and activity modification, physical therapy, nonsteroidal anti-inflammatory drugs and 
kinesio taping therapy seems to be consensual. The use of biological substances like 
autologous blood and platelet-rich plasma injection achieves good results and are indicated 
in refractory cases. Alternatively, corticoidsteroid injections can be used, with a positive 
short-term response but is associated with a high rate of recurrence and augmented tendon 
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degeneration. As last resource, surgical intervention is indicated and is associated with a 
high rate of success with no significant differences between the various surgicals 
techniques. Regardless these promising therapies for epicondylitis, continued research and 
randomized clinical trials are needed to enable determination of a consensual and globally 
accepted treatment algorithm. 
 
INTRODUCTION 
Epicondylitis, more frequently known as ǲtennis elbowǳ is a prevalent disease in general 
community and is usually self-limited in time. However, it can cause functional impairment, 
often associated with high morbidity leading to absence of work because of the pain and 
discomfort on the upper limb. 1 
The pathophysiology of the disease is not well understood. Initially, it was described to be 
a persistent inflammatory state, however actually it is considered a degenerative disease 
associated to overuse, resulting from microtraumas at the common extensor tendon 
originating from the epicondyle, specifically the tendon of origin of the extensor carpi 
radialis brevis (ECBR), and, in some cases, the extensor carpi radialis longus (ECRL) and 
extensor digitorum communis (EDC).The microtraumas result from repetitive contractions 
at the ECRB tendon with wrist extension and forearm supination and pronation, that may 
lead to micro tears, degeneration and tendinosis associated with an abnormal 
microvascular response. A very common cause is found in tennis players that undergo 
eccentric contractions of the ECRB during backhand tennis swing.2, 3Histologic findings 
support the thesis of a degenerative etiology, with the observation of lesions described as ǲangiofibroblastic hyperplasiaǳ tendinosis by Nirchl, that implies failure of natural tendon 
repair mechanism, rather than acute inflammation.4 
This condition has a world prevalence of 1 to 3%, affecting more frequently patient from 35 
to 55 years, with equal gender distribution. Some studies, shown an annual incidence of 4 
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to 7 per 1000 inhabitants. 5, 6Among tennis players the prevalence can achieve 14,1 % with 
an overall incidence of 35%. 7 Nonetheless, the nomenclature ǲtennis elbowǳ, the majority 
of the patients are not tennis players, but subjects that are manual workers. 6 
The diagnosis is generally clinical, consisting of pain and tenderness in the lateral region of 
the elbow at the epicondyle site, extending to dorsum of forearm and impaired function with 
weakness in grip strength. Pain is usually insidious with a sharp character. 2, 6 Symptoms 
may last from 6 months to 2 years, despite the majority of patients being total recovered within ͳʹ months with ǲwait and seeǳ approach. 8, 9 Ultrasound (US) has been used on 
diagnosis and follow-up, permitting the evaluation of the degenerated tissue. 10 Radiologic 
evaluation may reveal pathologic findings with calcifications on the tendon being present in 
about 25% of patients, mainly due to previous corticosteroids injections. 11 
Epicondylitis treatment is still controversial. The first approach is usually conservative, and 
includes rest and activity modification, nonsteroidal anti-inflammatory drugs (NSAID), 
bracing and physical therapy. In refractory cases, normally described as recalcitrant 
epicondylitis, injection therapy and surgical intervention may be indicated. 2, 8 
Despite being a prevalent disease little consensus exists on an exact treatment algorithm, 
therefore I am in this review to access actual state of art on epicondylitis treatment and to 
access the best management approach, focusing in the new promising treatments. 
 
MATERIALS and METHODS 
This literature review analyzes systematic reviews and clinical trials that contain 
information related to epicondylitis and its treatment in the last 5 years. 
A search for articles published between 2011 and 2016, written in English was performed 
in the PubMed / MEDLINE database, using a MeSH term: "Tennis Elbow"," Tennis Elbow/ 
surgery "," Tennis Elbow/ therapy "," Tennis Elbow/ drug therapy "," Tennis Elbow/ 
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rehabilitation ǲ. Comprehensive Keywords Lateral epicondylitis, autologous blood injection, 
rich platelet-derived plasma and surgical treatment were also used. Other reference articles 
in the Epicondylitis literature were also included. 
The articles were first selected by the titles and abstracts. In a second phase, the complete 
article was read and the information to be included in this literature review was extracted. 
 
EPICONDYLIYIS MANAGEMENT 
Traditionally, the first approach for epicondylitis management consists of conservative 
treatment with a ǲwait and seeǳ strategy, rest and activity modification. About 90% of 
patients will report improvement in 1 year of symptoms, nonetheless only 34% will account 
to full recovery at 12 months follow up. 12 
Initially, NSAID can be given for pain relieve. In this phase, other conservative treatments, 
namely physiotherapy, bracing and extracorporeal shockwave therapy, are possible. 
In recalcitrant epicondylitis, minimally invasive techniques are often used, being the most 
widely used the corticosteroid injection. In the last years, new promising therapies are 
focusing on the potential use of growth factors as stimulants for tendon repair and new 
injectable substances, namely botulinum toxin, autologous blood, platelet-rich plasma, 
polidacanol, glycosaminoglycan and prolotherapy are being described.13 
Surgery is usually the last resource for treatment. It is estimated that, only 4% to 11% of 
patients will need surgical treatment. It appears to be a consensus that surgery is indicated 
and achieves good results on patients with persisting pain, refractory to non-operative 





1. CONSERVATIVE TREATMENT – NON INVASIVE TECHNIQUES 
 
1.1 WAIT AND SEE APPROACH 
Epicondylitis is commonly a self-limited disease with a duration between 6-24 months, so 
the majority of the cases will reveal improvement on pain and grip strength parameters 
with an educational approach to avoid potential harmful movements of forearm and rest.6 
1.2 NSAID 
Oral or topical NSAID may improve pain in short term (first 4 weeks), with diclofenac being 
the most used.  However, limited evidence exists on long-term effectiveness, with some long 
follow-up studies not regarding any improvement on pain and grip strength. 5, 17 
1.3 PHYSIOTHERAPY (Exercises programs, manual therapy and manipulation) 
Exercises programs, with highlight on eccentric isotonic exercises 18 have been used in 
epicondylitis treatment as adjuvant therapy with significant improvements that may allow 
faster recovery and return to daily-living activities and sports.19, 20 
Manual therapy and manipulation of elbow and wrist are also being linked to a beneficial 
analgesic effect, that permit more vigorous exercises, resulting in improvement of pain and 
other functional parameters. 
Nonetheless, exercises programs and manual manipulation did not achieve a positive 
response when they are prescript alone and not as an adjuvant therapy.21-23 
1.4 BRACING 
Counterforce braces are supposed to reduce the level of tension on forearm extensors and, 
therefore facilitate the healing of degenerated tissue. Several studies have achieved positive 
results with this therapy with pain and grip strength improvements when associated with 
other complementary therapy.5, 21 
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1.5 KINESIO TAPING THERAPY (KTT) 
Kinesio taping therapy (KTT) technique is used on musculoskeletal sport-related diseases 
with satisfying results concerning to pain relief, muscle strength and functional movements 
restoration.  
The beneficial effect of KTT is thought to be related with dispersion and decompression of 
the stress generated by the muscle contraction and nociceptors inhibition that leads to 
reduction of painful inhibition and improves strength contraction.24 
Some recent studies have showed the potential positive effect of KTT on epicondylitis 
treatment when tape is applied by muscle technique from origin to insertion, leading to pain 
and grip strength parameters improvement. Whatsoever, few literature exists and more 
studies are need to prove exact efficacy of this technique on epicondylitis. 24, 25 
1.6 EXTRACORPOREAL SHOCKWAVE THERAPY (ESWT) 
ESTW is defined as a transient oscillation pressure locally applied and propagating on the 
targeted tissue, favoring tissue regeneration by inhibiting inflammatory response and 
promoting angiogenesis.26 Despite this therapy being widely used on sport related 
musculoskeletal tendinopathies, controversy exists, regarding its effectiveness with ESWT 
being associated with opposite results in different studies, since no effect at all to significant 
pain and grip improvement results, although US findings did not alter. The abysmal 
differences between studies are probably due to different treatment regime with 4-10 
weekly session being linked to better results. However, more studies are needed to 
determine exact optimal regime.10, 27, 28 
 





2.1 CORTICOIDSTEROIDS INJECTIONS (CSI) 
Since the description of epicondylitis, corticosteroids, specially hydrocortisone, have been 
widely used with controversial results. This treatment was initially introduced, as 
epicondylitis was thought to be an inflammatory disease. Today, the possible beneficial 
effects of CSI are attributed to an analgesic effect by inhibiting pain-modulating 
neurotransmitters. CSI have been consistently linked to a beneficial response in pain and 
grip strength in a short-term. However, on long term, several studies showed no evidence 
of effectiveness and in some cases, CSI were associated with harmful effects.5, 8, 29 
CSI have numerous lateral effects, including, skin atrophy and pigmentation, tendon 
atrophy and rupture, resulting in aggravated tendon degeneration. 29 Nevertheless, these 
complications are rare and CSI can be used with relatively safety rate. 
Controversy also exists, on proper location, technique, type and volume of corticosteroid 
for injection. Some studies show that peppering technique versus single shot injection, 
achieves better results, by stimulating local blood flow. 8 Most studies indicate maximum 
tenderness point, as being the best site to injection.13 
 
3. OTHER LOCAL TENDON INJECTIONS 
Alternative, less studied local tendon injection therapies have been described, with poorer 
results compared with corticosteroids and biological injections. 
3.1 BOTULINUM TOXIN A 
This substance can induce paralysis of extensor muscular group, reducing the resting tone 
of the muscles and preventing the continuous microtraumas, thereby permitting the 
degenerated tissues to auto-repair. This procedure has been proven to decrease pain 
intensity without a negative effect on grip strength, however lateral effects are usually 
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present with patients often reporting weakness in extension of wrist and fingers, especially 
the 3th, that may be not tolerated by certain patients.13, 30, 31 
3.2 GLYCOSAMINOGLYCAN - HYALURONIC ACID 
Glycosaminoglycan have been studied has possible treatment for epicondylitis. Hyaluronic 
acid, is a heavy weight glycosaminoglycan, that is present in synovial joints fluid and is used 
on knee osteoarthritis treatment with satisfying results. Some studies have also showed the 
effect of this substance on epicondylitis, achieving a positive clinical response with a safety 
profile. However, long follow-up studies determining its long term efficacy still not exist.  32, 
33 
3.3 POLIDOCANOL 
Polidocanol is a sclerosing and a local anesthetic agent, used in varicose veins. It is being 
recently applied in epicondylitis treatment with some studies revealing modest results, with 
pain recovery being similar to placebo. Although some improvement in tendon thickness, 
echogenicity and hyperemia has been proved. 
At this point it is not possible to recommend polidacanol for epicondylitis management as 
more studies are needed to access better comprehension on polidacanol effectiveness.13, 34 
3.4 PROLOTHERAPY 
Prolotherapy induces tissue regeneration by local injection of an irritant solution. This will 
produce an augment cells growth, promoting the tissue healing. Most used solutions are 
hypertonic dextrose and morrhuate sodium. Some studies have proved the beneficial effect 
of this technique, with a clinically significant reduction on pain compared to placebo and US 
evidence of healing on a short term. 35 Others studies concluded that prolotherapy were 
only effective as adjuvant therapy,36 so more studies are needed to confirm effectiveness of 




4. PROMISSING BIOLOGICAL INJECTIONS 
 
4.1 AUTOLOGOUS BLOOD INJECTION (ABI) and PLATELET RICH PLASMA INJECTION 
(PRP) 
The role of mitomorphogenic factors of blood in the healing of degenerated tendon are the 
basis for the development of ABI and PRP injections.37 It is hypothesized that these 
biological substances will induce angiogenesis, increase growth factors expression and 
recruitment and proliferation of cells implicated in regeneration, mainly because of platelet 
factors effects.1, 38 This changes will provide the required cellular and humoral environment 
to induce a healing cascade and subsequent vascularization and regeneration of the tendon. 
39 Theoretically, PRP will have a better clinical response, since concentration of platelets are 
higher in this modality.16 
The solution of ABI is acquired by collecting peripheral venous blood on the ipsilateral arm. 
For PRP the collected blood must be centrifuged to obtain an augmented platelet 
concentration solution. A variation of ABI and PRP, called autologous conditioned plasma 
(ACP) with an intermediary concentration of platelets can also be obtained by 
centrifugation process.40 Finally, the solution is injected at the epicondyle in the maximal 
tenderness point. 1 
The injection procedure should be guided by US placed longitudinally, parallel to the 
common tendon. The needle then should advance longitudinally until attach bone contact. 
Then the solution should be injected from 3-4 passages, so solution range superficial, 
medium and deep fibers using peppering technique. Some authors recommend prior 
injection of lidocaine for analgesic effect.29, 38 
After injection, local pain can exist and should be controlled with paracetamol and 
cryotherapy. NSAID and other anti-inflammatory are not recommended as it may interfere 
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with platelet function.1, 29 Some authors also recommend using a brace for a brief time, 
usually 1 week, 2 cm below the maximal tenderness point.37, 38 
4.2 STEM CELLS THERAPY 
In the last years there has been an increase enthusiasm on stem cells application in multiple 
musculoskeletal diseases. These cells are proved to promote cells differentiation and 
regeneration and reduce tissue inflammation. 
Thereby, utilization of stem cells on epicondylitis is being studied, with some pilot studies 
showing some promising outcomes, comparable to those on PRP therapy in pain, functional 
impairment and tissue regeneration patterns. However, larger and longer follow up studies 
are needed to prove stem cells efficacy and safety profile.41-43 
 
5. SURGICAL INTERVENTION 
Surgical management of epicondylitis was first described by Nirschl and Petrone in 1973 
with an open procedure that was linked to an 97,7% improvement rate and able patients to 
return to sports in 85,2% of the cases.44 Later studies did not achieve such excellent results 
but achieved good outcomes. 
Open, arthroscopic and percutaneous approaches have been described. The surgical 
procedures focus on ERCB release and/or debridement, epicondyle denervation, 
decortication of epicondyle and anconeus flap. These procedures have been tried alone or 
combined with similar results, existing a consensus on effectiveness of the different surgical 
approaches in 6-month long recalcitrant epicondylitis.45-48 
5.1 OPEN APROACH 
Since 1973, Nirshl procedure is being used with little variations from the original technique. 
It consists of an oblique incision anterior to epicondyle, separation of ERCL and EDC, with 
posterior visualization of ERCB under EDC tendon. Debridement of the degenerative tissue 
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and release of ERCB tendon from its insertion in epicondyle. Degenerative tissue in EDC 
tendon should also be debrided. Finally, ERCL and EDC tendons must be sutured and the 
wound closed. Two of the most commons variations to this technique are the addition of 
epicondyle decortications and anconeus muscle transfer to cover the tendon when 
extensive debridement is made.44, 46, 49 
The key element for surgery success is the complete withdraw of the degenerated tissue 
that is easier to attain in the open approach with resource to a scratch maneuver described 
by Nirschl.11, 46 
Denervation of epicondyle as also been described as an alternative to Nirschl technique. In 
this case, the patients are previously submitted to a diagnostic injection anesthetic agent. If 
this evolve to a positive response, with pain and grip strength improvement, the 
denervation itself is performed. The procedure consists of transverse incision proximal to 
epicondyle, identification of the posterior branches of the posterior cutaneous nerve of the 
forearm, injection of bupivacaine and transection of the nerves. The nerves are then buried 
posteriorly in the lateral head of the triceps. This procedure has the advantage of allowing 
an immediately resume to normal daily activities. 9 
5.2 ARTHROSCOPIC APPROACH 
Arthroscopic approach was described by Baker and consists of a releasement of the joint 
capsule, permitting extracapsular ERCB visualization. The origin of ERCB and portion of the 
ERCL and EDC are debrided and the epicondyle can also be decorticated. This approach has 
the advantage of allowing the assessment and treatment of intra-articular pathology, which 
is thought to be present in about 25% of the cases.11, 49, 50 
5.3 PERCUTANEOUS APPROACH 
This approach was first designed by Baumgard and Schwartz [114]. It consists of a skin 
incision of 5-10mm on the anterior aspect of the epicondyle. After incision the blade in 
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moved anteriorly and inferiorly to complete release of common extensor tendon origin. 




For the past 5 years, several studies have evaluated the effectiveness of the different 
epicondylitis therapies, trying to access the best management approach to this pathology. 
Despite the numerous studies found in literature, it still does not exist an international 
consensus and a globally accepted treatment algorithm. 
Recent utilization of biological injections is being linked to good results despite controversy 
exists. A prospective long term study accessing the effectiveness of ABI in recalcitrant 
epicondylitis demonstrated a significantly decrease in pain and functional impairment with 
persisting results in a 3-years follow-up. Patients satisfaction achieved 80% at 6th month 
and 85% in 3rd year. 37 
Several randomized controlled trials have demonstrated that ABI is significantly more 
effective than CSI in a long follow-up, permitting to achieve a 90% success rate with CSI 
achieving a faster improvement of pain but associated with higher rate of recurrence.39  
Studies comparing PRP and CSI also revealed that VAS pain score and functional q-DASH 
score, achieved better results with CSI in 15-31 days, however at the 3-month final follow-
up, VAS score were better on PRP group with a significant difference. Grip strength has been 
also demonstrated to improve significantly with PRP therapy at a 3-month follow-up. 52 
Another study comparing PRP with CSI on clinical and US findings improvement, revealed 
that CSI achieved a peek of clinical improvement only at the 3rdmonth with subsequent 
decrease at the 6th month with recurrence of symptoms in 47,6% of patients. Comparing the 
US findings at the final follow-up, CSI was related to diminished thickness of the tendon and 
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epicondyle cortical erosion while PRP was related to augmented thickness of tendon. These 
US finding support the thesis that CSI at long term aggravates the degeneration process, 
while PRP stimulates a healing response.29  
A recent study, comparing ACP and CSI also revealed a faster and significant DASH score 
improvement in CSI group at 6 weeks and 6 months, but at 1 year PRP was significantly 
better, being associated with ǲvery goodǳ results compared with only ǲfairǳ results in CSI 
group.40 
Few studies were made on the past 5 years, comparing ABI and PRP effectiveness on 
epicondylitis. A randomized clinical trial comparing these treatments, achieved comparable 
results, with significant VAS pain score and Pressure Pain Threshold score improvement in 
both groups on a 4-week to 12-month follow-up. Success was achieved in both groups with 
no statically difference, revealing that there was no advantage on the centrifugation process 
of autologous blood to produce PRP instead prompt use of ABI. 38 
Although several studies support the use of PRP and ABI, some studies exist that raise 
doubts on their effectiveness. A study comparing PRP to placebo (saline injections) revealed 
that both groups were associated with a global pain decrease in a 6-12month follow-up. 
Despite the PRP group showed better results, there were no statistical significant 
differences between groups, revealing that PRP was no better than saline injections at 12-
month follow-up. 16 Another trial comparing ACP versus dry-needling procedure 
demonstrated that no statistical differences in VAS pain score were found between groups 
at a 2-6month follow-up, despite ACP group achieved a slightly higher clinical improvement, 
especially in a short term.53 
A wide range of experimental surgical technique are being described in recent literature.  
A variation of Nirschl procedure with the addition of anconeus flap to the debridement of 
the tendon, achieved significant clinical improvement compared with simply debridement, 
in pain and functional impairment and no apparent augmented risks of complications.45 
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Among the new promising surgical techniques, percutaneous tenotomy, have been related 
to significant decrease on pain scores and ͳͲͲ% patient’s satisfaction on a ͵-year follow-
up. 54 Another promising procedure, the epicondyle denervation, was also related to ǲexcellentǳ results, with 80% of patients showing improvement on pain and grip strength 




Epicondylitis is a prevalent disease with an important pain and functional impairment that 
can lead to absence of work and serious daily-living activities limitations. Despite being a 
common condition, there is not a consensus on treatment algorithm. Whatsoever a 
treatment algorithm [Figure I] can be proposed with a first line approach consisting on a 
conservative treatment with rest, activity modification, physical therapy, NSAID, kinesio 
taping therapy and extracorporeal shockwave therapy that seems to achieve consensus as 
first line treatment in a wide range of studies. 
The majority of patients will need further invasive treatment, so second line approach can 
be proposed with autologous blood or platelet-rich plasma injections being indicated in 
patients that fail to respond to conservative treatment as several studies are showing good 
results with significant pain and strength improvements and patients satisfaction with 
these injection therapies. Alternatively, CSI can be used in this phase with caution on the 
long term lateral effects with high rate of recurrence and augmented tendon degeneration. 
When epicondylitis is refractory to conservative, non-invasive and invasive treatment for 
more than 6 months, surgical intervention is indicated as third line approach for 
epicondylitis treatment, being associated with a high rate of success on all three, open, 
arthroscopic and percutaneous approaches with no significant differences between them. 
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Continued research and randomized clinical trials are needed to enable determination of a 
consensual and globally accepted treatment algorithm. 
 
Figure I: Proposal of an 
Epicondylitis Treatment Algorithm; 
Bold boxes indicate the treatments 
associated with most satisfying 
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Normas	  de	  publicação	  
	  
	   	  
	   Objectivos	  e	  âmbito	  
	   	  
	   A	   Acta	   Reumatológica	   Portuguesa	   (ARP)	   é	   uma	   publicação	   científica	   internacional,	  
revista	   por	   pares,	   abrangendo	   aspectos	   clínicos	   e	   experimentais	   das	   doenças	   reumáticas.	   São	  
publicados	  artigos	  originais,	  artigos	  de	  revisão,	  casos	  clínicos,	  imagens	  em	  Reumatologia,	  cartas	  
ao	  editor	  e	  artigos	  que	  visam	  melhorar	  a	  Prática	  Clínica	  (recomendações	  e	  protocolos	  clínicos,	  
por	  exemplo).	  
	   A	  ARP	   foi	   fundada	  em	  1973	   como	  orgão	   científico	  oficial	   da	   Sociedade	  Portuguesa	  de	  
Reumatologia	   e	   subscreve	   os	   requisitos	   para	   apresentação	   de	   artigos	   a	   revistas	   biomédicas	  
elaboradas	   pela	   Comissão	   Internacional	   de	   Editores	   de	   Revistas	   Médicas	   (International	  
Commitee	  of	  Medical	  Journal	  Editors),	  publicada	  na	  íntegra	  inicialmente	  em	  N	  Engl	  J	  Med	  1991;	  
324:	   42428	   e	   actualizada	   em	   Outubro	   de	   2008	   e	   disponível	   em	   www.ICMJE.org.	   A	   política	  
editorial	   da	   ARP	   segue	   as	   Recomendações	   de	   Política	   Editorial	   (Editorial	   Policy	   Statements)	  
emitidas	   pelo	   Conselho	   de	   Editores	   Científicos,	   disponíveis	   em	  
http://www.councilscienceeditors.org/files/public/entire_whitepaper.pdf.	  
	   A	   ARP	   publica	   preferencialmente	   artigos	   escritos	   na	   língua	   Inglesa.	   Caso	   os	   autores	  
optem	  por	  submeter	  em	  Português,	  poderá	  ser	  solicitada	  a	  sua	  tradução	  para	  a	  língua	  Inglesa.	  O	  
rigor	   e	   a	   exactidão	   dos	   conteúdos,	   assim	   como	   as	   opiniões	   expressas,	   são	   da	   exclusiva	  
responsabilidade	  do(s)	  autor(es).	  
	   Os	   artigos	   submetidos	   	   devem	   ser	   originais	   e	   não	   podem	   ter	   sido	   publicados	  
previamente.	  
	   Os	   artigos	   publicados	   constituirão	   propriedade	   da	   revista,	   não	   podendo	   ser	  
reproduzidos,	  no	  seu	  todo	  ou	  em	  parte,	  sem	  a	  prévia	  autorização	  dos	  editores.	  
	   A	  Revista	  está	  indexada	  no	  PubMed/Medline	  e	  os	  seus	  artigos	  estão	  disponíveis	  online	  
na	  íntegra,	  com	  acesso	  aberto	  e	  gratuito.	  
	   Instruções	  para	  submissão	  de	  artigos	  
	   A	   Acta	   Reumatológica	   Portuguesa	   oferece	   aos	   autores	   um	   sistema	   de	   submissão	   e	  
revisão	   de	   artigos	   a	   funcionar	   exclusivamente	   online.	   Acedendo	   ao	   website	   da	   ARP	  
(www.actareumatologica.pt)	  os	  autores	  poderão	  submeter	  os	  seus	  artigos	  e	  acompanhar	  o	  seu	  
estado	  no	  processo	  de	   revisão.	  Os	  autores	   serão	  notificados	  por	  email	  no	  próprio	  dia	  em	  que	  
o(s)	  seu(s)	  artigo(s)	  sofra(m)	  alterações	  relevantes	  durante	  o	  processo	  editorial.	  	  	  
De	  modo	  a	  submeter	  um	  manuscrito,	  os	  autores	  deverão	  criar	  uma	  conta	  de	  utilizador:	  
-­‐	   	   	   	  Aceder	  ao	  website	  da	  ARP	   (www.actareumatologica.pt),	   clicar	  no	   link	   “Entrar”,	   seguido	  de	  
“Registo”	  e	  seguir	  cuidadosamente	  todas	  as	   instruções	  fornecidas.	  Um	  email	  de	  activação	  será	  
enviado	  para	  a	  sua	  conta	  de	  email.	  Para	  activar	  a	  conta	  ARP	  é	  necessário	  seguir	  o	  link	  fornecido	  
no	  corpo	  desse	  email,	  que	  automaticamente	  o	  redirecionará	  para	  uma	  mensagem	  de	  registo	  no	  
website	  da	  ARP.	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Após	   a	   criação	   de	   uma	   conta	  ARP,	   os	   autores	   poderão	   submeter	   e	   acompanhar	   o	   progresso	  
do(s)	  seu(s)	  artigo(s):	  	  
-­‐ Aceder	  ao	  website	  da	  ARP	  (www.actareumatologica.pt),	  entrar	  na	  area	  privada	  e	  clicar	  no	  
link	  “Submeter	  artigo”.	  Preencher	  o	  formulário	  seguindo	  as	  instruções	  cuidadosamente.	  
	  
Instruções	  	  aos	  autores	  
	   Para	   evitar	   atrasos	   no	   processo	   de	   revisão,	   leia	   cuidadosamente	   as	   instruções	   e	  
assegure-­‐se	   de	   que	   o	   seu	   manuscrito	   está	   de	   acordo	   com	   os	   requisitos	   da	   ARP	   antes	   de	  
submeter	  (número	  de	  palavras	  e	  formato).	  
	   -­‐	  Título	  do	  artigo:	  o	  título	  deve	  descrever	  brevemente	  o	  conteúdo	  do	  artigo.	  Não	  devem	  
ser	  usadas	  abreviaturas.	  Deve	  ser	  indicado	  um	  curto	  título	  para	  rodapé.	  Nos	  artigos	  escritos	  em	  
português	  é	  necessário	  incluir	  o	  título	  em	  inglês.	  
	   -­‐Nome	  dos	  autores	  e	  afiliações	  
	   -­‐	   Informações	   do	   autor	   responsável	   pela	   correspondência:	   nome,	  morada,	   telefone	   e	  
endereço	  electrónico	  
	   -­‐	  Resumo:	  com	  um	  máximo	  de	  350	  palavras	  ,deve	  incluir	  objectivos,	  material	  e	  métodos,	  
resultados	  e	  conclusões.	  Para	  os	  casos	  clínicos	  o	  limite	  de	  palavras	  é	  180.	  
Tipos	  de	  artigo:	  
-­‐ Editoriais:	  Os	  Editoriais	  serão	  solicitados	  por	  convite	  do	  Editor	  e	  constituirão	  comentários	  
sobre	   tópicos	   actuais	   ou	   sobre	   artigos	   publicados	   na	   revista.	   O	   texto	   dos	   Editoriais	   não	  
deverá	  exceder	  as	  1200	  palavras,	  um	  máximo	  de	  15	  referências	  e	  pode	  conter	  uma	  figura	  
ou	  tabela.	  
-­‐ Artigos	   de	   Revisão:	   Preferencialmente,	   os	   Artigos	   de	   Revisão	   serão	   também	   solicitados	  
pelo	   Editor.	   No	   entanto,	   os	   autores	   interessados	   em	   apresentar	   um	   Artigo	   de	   Revisão	  
podem	   contactar	   o	   Editor	   para	   discussão	   dos	   temas	   a	   apresentar	   no	   artigo,	   o	   qual	   não	  
deverá	  exceder	  as	  4000	  palavras,	  6	  Tabelas	  ou	  Figuras	  e	  100	  referências;	  
-­‐ Artigos	  Originais:	  O	  texto	  dos	  Artigos	  Originais	  deve	  ser	  apresentado	  com	  uma	  Introdução,	  
Material	   e	   Métodos,	   Resultados,	   Discussão	   e	   Conclusão.	   Não	   deverá	   exceder	   as	   4000	  
palavras,	  6	  Tabelas	  ou	  Figuras	  e	  60	  referências;	  
-­‐ Prática	   Clínica:	   O	   texto	   dos	   artigos	   de	   Prática	   Clínica	   deve	   ser	   apresentado	   com	   uma	  
Introdução,	  Material	  e	  Métodos,	  Resultados,	  Discussão	  e	  Conclusão.	  Não	  deverá	  exceder	  as	  
4000	  palavras,	  6	  Tabelas	  ou	  Figuras	  e	  60	  referências;	  
-­‐ Casos	   Clínicos:	   O	   texto	   dos	   Casos	   Clínicos	   deverá	   ser	   apresentado	   com	   uma	   Introdução,	  
Caso	   Clínico	   e	   Discussão.	   Os	   Casos	   Clínicos	   deverão	   ser	   acompanhados	   de	   figuras	  
ilustrativas/tabelas	  (máximo	  de	  6),	  não	  deverão	  exceder	  as	  2000	  palavras	  e	  25	  referências;	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-­‐ Imagens	   em	   Reumatologia:	   	   Imagens	   representando	   manifestações	   clínicas	   raras	   ou	   de	  
particular	   interesse	   podem	   ser	   submetidas	   (no	   máximo	   4).	   O	   texto	   acompanhante	   não	  
deverá	  exceder	  as	  500	  palavras	  e	  5	  referências	  
-­‐ Cartas	  ao	  Editor:	  As	  Cartas	  ao	  Editor	  deverão	  constituir	  um	  comentário	  critico	  a	  um	  artigo	  
da	   Revista	   ou	   uma	   pequena	   nota	   sobre	   um	   tema	   ou	   caso	   clinico.	   O	   texto	   não	   deverá	  
exceder	  as	  600	  palavras,	  uma	  Figura/Tabela	  e	  um	  máximo	  de	  10	  referências.	  	  
	  
Tabelas:	   As	   Tabelas	   a	   inserir	   devem	   ser	   assinaladas	   no	   texto	   em	   numeração	   romana.	   Cada	  
Tabela	  deverá	  possuir	  um	  título	  e	  não	  deverá	  apresentar	  linhas	  verticais.	  As	  linhas	  horizontais	  só	  
deverão	   ser	   usadas	   como	   separadores	   de	   título	   e	   subtítulos.	   Todas	   as	   abreviaturas	   usadas	  
devem	  ser	  explicadas	  na	  parte	  inferior	  da	  Tabela.	  
Figuras:	  As	  Figuras	  a	  inserir	  devem	  ser	  assinaladas	  no	  texto	  em	  numeração	  árabe	  e	  apresentar	  
legendas.	   Cada	   Figura	   deve	   ser	   importada	   individualmente	   em	   format	   JPEG	   ou	   TIFF	   de	   alta	  
qualidade.	  O	  Editor	   reserva	  o	  direito	  de	  agrupar	  Figuras	  ou	  alterar	  o	   seu	   tamanho	  de	  modo	  a	  
rentabilizar	  o	  uso	  da	  páginas.	  
Referências:	  As	  Referências	  bibliográficas	  devem	  ser	   classificadas	  e	  numeradas	  por	  ordem	  de	  
entrada	  no	  texto	  e	  em	  superscript.	  As	  abreviaturas	  usadas	  na	  nomeação	  das	  revistas	  devem	  ser	  
as	  utilizadas	  pelo	   Index	  Medicus.	  Nas	  Referências	   com	  6	  ou	  menos	   autores,	   todos	  devem	   ser	  
nomeados.	   Nas	   Referências	   com	   7	   ou	   mais	   autores,	   devem	   ser	   nomeados	   os	   3	   primeiros	  
seguidos	  de	  et	  al.	  Os	  números	  de	  página	  inicial	  e	  final	  devem	  ser	  totalmente	  apresentados	  (ex.	  
565-­‐569	   e	   não	   565-­‐9).	   Não	   indicar	   o	   número	   da	   Revista	   nem	   o	   mês	   da	   publicação.	   As	  
Referências	   correspondentes	   a	   trabalhos	   não	   publicados,	   apresentações	   ou	   observações	  
pessoais,	   devem	   ser	   inseridas	   no	   próprio	   texto	   (em	   parenthesis)	   e	   não	   como	   Referências	  
convencionais.	  Os	  autores	  são	  responsáveis	  pela	  exactidão	  das	  Referências	  apresentadas.	  
Seguem-­‐se	  alguns	  exemplos	  de	  como	  devem	  constar	  os	  vários	  tipos	  de	  Referências:	  
	   Revista	  
	   Nome(s)	   e	   iniciais	   do(s)	   autor(es).	   Título	   do	   artigo.	   Nome	   da	   Revista	   Ano;	   Volume:	  
	   Página	  (s).	  
Ex:	  Hill	   J,	  Bird	  HA,	  Hopkins	  R,	  Lawton	  C,	  Wright	  C.	  Survey	  of	  satisfaction	  with	  care	   in	  a	  
rheumatology	  outpatient	  clinic.	  Ann	  Rheum	  Dis	  1992;	  51:	  195-­‐197.	  
	  
	   Artigo	  publicado	  online	  (inserir	  DOI)	  
	   Nome(s)	   e	   iniciais	   do(s)	   autor(es).	   Título	   do	   artigo.	  Nome	  da	  Revista	   Published	  Online	  
	   First:	  data.	  doi.	  
Ex:	   Merkel	   PA,	   Curthbertson	   D,	   Hellmich	   B	   et	   al.	   Comparison	   of	   disease	   activity	  
measures	  for	  ANCA-­‐associated	  vasculitis.	  Ann	  Rheum	  Dis	  Published	  Online	  First:	  29	  July	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   Capítulo	  de	  livro	  
	   Nome(s)	  e	   iniciais	  do(s)	  autor(es)	  do	  capítulo.	  Título	  do	  capítulo.	   In:	  Nome(s)	  e	   iniciais	  
	   do(s)	   editor(es)	   medico(s).	   Título	   do	   livro.	   Cidade:	   Nome	   da	   casa	   editorial,	   ano	   de	  
	   publicação:	  primeira	  a	  última	  página	  do	  capítulo.	  
	   Ex:	  Stewart	  AF.	  Hypercalcemia	  resulting	  from	  medications.	   In:	  Favus	  MD,	  ed	  Primer	  on	  
	   the	  Metabolic	   Bone	  Diseases	   and	  Disorders	   of	  Mineral	  Metabolism.	  New	   York:	   Raven	  
	   Press,	  1991:	  177-­‐178.	  
	  
	   Livro	  
	   Nome(s)	  e	  iniciais	  do(s)	  autor(es).	  Título	  do	  livro.	  Cidade:	  Nome	  da	  casa	  editorial,	  ano	  de	  
	   publicação:	  página(s).	  
	   Ex:	   Lorig	  K.	  Patient	  Education.	  A	  practical	   approach.	   St	   Louis:	  Mosby-­‐Year	  Book,	  1992:	  
	   51.	  
	  
	   Documento	  electrónico	  
	   Título	  do	  documento.	  http://address.	  Data	  de	  acesso.	  
	   Ex:	   Programa	  Nacional	   de	   Luta	   Contra	   a	   Tuberculose.	   Sistema	  de	  Vigilância	   (SVIG-­‐TB).	  
	   Direcção-­‐Geral	   da	   Saúde	   –	   Divisão	   de	   Doenças	   Transmissíveis,	   Março	   de	   2005.	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Processo	  de	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Os	   artigos	   submetidos	   são	   enviados	   a	   revisores	   especializados	   no	   tema	   do	   artigo.	  
Concluída	  a	  revisão	  do	  artigo,	  os	  autores	  são	  notificados,	  recebendo	  os	  pareceres	  e	  comentários	  
dos	   revisores	   acerca	   do	   estado	   do	   mesmo.	   Com	   base	   nesses	   pareceres,	   os	   autores	   deverão	  
editar	  o	  artigo,	  corrigi-­‐lo	  e	  resubmetê-­‐lo	  para	  nova	  revisão.	  Na	  resubmissão	  de	  um	  artigo	  terão	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   ser	   incluídas	   em	   anexo	   uma	   carta-­‐resposta	   aos	   Revisores	   e	   um	   .doc	   com	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   versão	   do	  
artigo	   em	   track	   changes.	   Este	   documento	   não	   deverá	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   autores	  
nem	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  retirar	  do	  processo	  de	  revisão.	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  publicação	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  originalidade	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  artigo	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first”	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  os	  Editores	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  para	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  digital	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artigo	   para	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   as	   provas	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   que	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   e	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   e	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  os	  Editores	  no	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  em	  que	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  alterações.	  Apenas	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  alterações	  
e	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